Source: Medical Properties Trust's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$541.14M
$704.75M
$784.52M
$854.20M
$1.25B
$1.54B
$1.54B
$871.80M
$995.55M
$972.02M
Cost of revenue
—
—
$84.17M
$168.21M
$30.14M
$101.44M
$167.42M
$110.07M
$74.17M
$90.31M
Gross profit
—
—
$700.35M
$685.99M
$1.22B
$1.44B
$1.38B
$761.73M
$921.38M
$881.72M
Operating income
$341.64M
$485.58M
—
—
—
—
—
—
—
—
Interest expense
$159.60M
$176.95M
$223.27M
$237.83M
$328.73M
$367.39M
$359.04M
$411.17M
$417.82M
$510.36M
Pre-tax income
$219.11M
$293.92M
$1.02B
$373.78M
$463.33M
$730.89M
$959.72M
-$686.77M
-$2.36B
-$237.32M
Income tax
-$6.83M
$2.68M
$927.00K
-$2.62M
$31.06M
$73.95M
$55.90M
-$130.68M
$44.10M
$38.62M
Net income
$225.05M
$289.79M
$1.02B
$374.68M
$431.45M
$656.02M
$902.60M
-$556.48M
-$2.41B
-$277.05M
EBITDA
$439.24M
$617.56M
—
—
—
—
—
—
—
—
EPS (basic)
$0.86
$0.82
$2.77
$0.87
$0.81
$1.11
$1.50
$-0.93
$-4.02
$-0.46
EPS (diluted)
$0.86
$0.82
$2.76
$0.87
$0.81
$1.11
$1.50
$-0.93
$-4.02
$-0.46
Diluted shares
261.07M
350.44M
366.27M
428.30M
530.46M
590.14M
598.84M
598.52M
600.25M
600.89M
Gross margin
—
—
89.3%
80.3%
97.6%
93.4%
89.1%
87.4%
92.6%
90.7%
Operating margin
63.1%
68.9%
—
—
—
—
—
—
—
—
Net margin
41.6%
41.1%
129.6%
43.9%
34.5%
42.5%
58.5%
-63.8%
-242.1%
-28.5%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$83.24M
$171.47M
$820.87M
$1.46B
$549.88M
$459.23M
$235.67M
$250.02M
$332.33M
$540.86M
Total assets
$6.42B
$9.02B
$8.84B
$14.47B
$16.83B
$20.52B
$19.66B
$18.30B
$14.29B
$15.00B
Long-term debt
$2.91B
$4.90B
$4.04B
$7.02B
$8.87B
$11.28B
$10.27B
$10.06B
$8.85B
$9.70B
Total debt
$2.91B
$4.90B
$4.04B
$7.02B
$8.87B
$11.28B
$10.27B
$10.06B
$8.85B
$9.70B
Total liabilities
$3.17B
$5.19B
$4.28B
$7.44B
$9.49B
$12.07B
$11.06B
$10.67B
$9.46B
$10.39B
Shareholders' equity
$3.25B
$3.82B
$4.55B
$7.03B
$7.34B
$8.44B
$8.59B
$7.63B
$4.83B
$4.61B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$263.84M
$362.24M
$449.09M
$494.12M
$617.64M
$811.66M
$739.01M
$505.79M
$245.48M
$230.77M
Free cash flow
$263.84M
$362.24M
$449.09M
$494.12M
$617.64M
$811.66M
$739.01M
$505.79M
$245.48M
$230.77M
Investing cash flow
-$926.54M
-$2.36B
$564.18M
-$4.88B
-$2.95B
-$3.86B
$396.06M
$517.56M
$1.32B
-$264.74M
Financing cash flow
$552.56M
$2.07B
-$345.87M
$5.04B
$1.40B
$2.95B
-$1.34B
-$1.02B
-$1.48B
$228.08M
Share buybacks
—
—
—
—
—
—
$17.94M
—
—
$23.44M
Stock-based compensation
$7.94M
$9.95M
$16.50M
$32.19M
$47.15M
$52.11M
$49.42M
$33.25M
$32.98M
$25.75M
Depreciation & amortization
$97.60M
$131.98M
$141.49M
$156.57M
$275.95M
$333.78M
$345.58M
$616.13M
$453.75M
$272.82M
Income statement
quarters · USD
Quarter ended
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
$337.39M
$306.58M
-$122.38M
$271.32M
$266.56M
$225.83M
$231.84M
$223.80M
$240.36M
$237.52M
$270.34M
$252.06M
Cost of revenue
-$28.67M
$28.77M
-$72.08M
$40.88M
$4.32M
$7.84M
$21.13M
$81.41M
$19.76M
-$22.29M
$11.43M
$97.33M
Gross profit
$366.07M
$277.81M
-$50.30M
$230.43M
$262.24M
$217.99M
$210.72M
$142.39M
$220.60M
$259.81M
$258.91M
$154.73M
Interest expense
$104.47M
$106.71M
$102.34M
$108.69M
$101.43M
$106.24M
$101.47M
$115.80M
$129.71M
$132.40M
$132.46M
$133.33M
Pre-tax income
-$190.69M
$126.95M
-$659.60M
-$864.43M
-$305.10M
-$791.90M
-$402.76M
-$108.58M
-$88.27M
-$66.58M
$26.10M
$285.00K
Income tax
-$148.26M
$10.06M
$3.98M
$10.95M
$14.56M
$9.03M
$9.56M
$9.44M
$9.80M
$10.87M
$8.51M
-$32.82M
Net income
-$42.04M
$116.71M
-$663.94M
-$875.62M
-$320.63M
-$801.16M
-$412.85M
-$118.28M
-$98.36M
-$77.73M
$17.31M
$32.83M
EPS (basic)
$-0.07
$0.19
$-1.11
$-1.46
$-0.54
$-1.34
$-0.69
$-0.20
$-0.16
$-0.13
$0.03
$0.05
EPS (diluted)
$-0.07
$0.19
$-1.11
$-1.46
$-0.54
$-1.34
$-0.69
$-0.20
$-0.16
$-0.13
$0.03
$0.05
Diluted shares
598.34M
598.55M
112.00K
600.30M
600.06M
600.23M
51.00K
600.59M
600.81M
601.14M
25.00K
597.72M
Gross margin
108.5%
90.6%
41.1%
84.9%
98.4%
96.5%
90.9%
63.6%
91.8%
109.4%
95.8%
61.4%
Net margin
-12.5%
38.1%
542.5%
-322.7%
-120.3%
-354.8%
-178.1%
-52.8%
-40.9%
-32.7%
6.4%
13.0%
Balance sheet
quarters · USD
Quarter ended
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Cash & equivalents
$324.05M
$340.06M
$250.02M
$224.34M
$606.55M
$275.62M
$332.33M
$673.48M
$509.83M
$396.58M
$540.86M
$425.00M
Total assets
$19.20B
$19.00B
$18.30B
$17.30B
$16.19B
$15.24B
$14.29B
$14.85B
$15.15B
$14.92B
$15.00B
$14.76B
Long-term debt
$10.24B
$10.16B
$10.06B
$10.10B
$9.37B
$9.22B
$8.85B
$9.47B
$9.65B
$9.62B
$9.70B
$9.66B
Total debt
$10.24B
$10.16B
$10.06B
$10.10B
$9.37B
$9.22B
$8.85B
$9.47B
$9.65B
$9.62B
$9.70B
$9.66B
Total liabilities
$10.89B
$10.72B
$10.67B
$10.60B
$10.00B
$9.80B
$9.46B
$10.09B
$10.32B
$10.26B
$10.39B
$10.22B
Shareholders' equity
$8.31B
$8.28B
$7.63B
$6.70B
$6.19B
$5.44B
$4.83B
$4.76B
$4.83B
$4.66B
$4.61B
$4.54B
Cash flow
quarters · USD
Quarter ended
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Operating cash flow
$76.53M
$158.19M
$135.42M
$74.34M
$35.26M
$59.20M
$76.69M
$384.00K
$51.75M
$18.57M
$160.06M
-$14.26M
Free cash flow
$76.53M
$158.19M
$135.42M
$74.34M
$35.26M
$59.20M
$76.69M
$384.00K
$51.75M
$18.57M
$160.06M
-$14.26M
Investing cash flow
$391.82M
-$61.66M
$170.22M
-$119.26M
$1.20B
$143.75M
$91.74M
-$89.42M
-$72.32M
-$95.14M
-$7.87M
-$76.78M
Financing cash flow
-$461.82M
-$66.66M
-$402.73M
$22.07M
-$853.52M
-$548.13M
-$99.81M
$426.32M
-$154.80M
-$34.46M
-$8.98M
-$23.22M
Stock-based compensation
$6.44M
$11.45M
$3.53M
$7.63M
$8.52M
$14.43M
$2.40M
$17.66M
$857.00K
$12.34M
-$5.12M
$573.00K
Depreciation & amortization
$367.97M
$80.65M
$79.93M
$77.21M
$103.86M
$206.47M
$66.20M
$65.43M
$68.24M
$69.48M
$69.67M
$73.35M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.